In the absence of hard evidence, US medical associations and the National Institutes of Health have not recommended remdesivir for treatment of Covid-19 so far
from Latest News https://ift.tt/2Y4YEtq
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Gilead's Covid-19 cure trial may yield results ahead of schedule: Report
Saturday, April 25, 2020
Related Posts:
ICICI Bank, L&T, SBI, Axis Bank gain over 15% in Sensex's 2000-point rallyHDFC, Maruti Suzuki India, Reliance Industries, Bharti Airtel and Adan… Read More
Wives who defendIn the real world, the spectacle of a wife sticking up for a husband w… Read More
Crude oil futures up 0.52 per cent to Rs 4,091 on firm trend overseasAnalysts said rise in crude oil futures was largely in tandem with pri… Read More
Work culture of the futureEvery cog in the wheel must present its unique services at the moment … Read More
0 comments: